The Conference on Cell & Gene Therapy for HIV Cure

August 17-18, 2017

Fred Hutchinson Cancer Research Center

Seattle, Washington | USA

The defeatHIV Martin Delaney Collaboratory, in collaboration with the Fred Hutchinson Cancer Research Center, the University of Washington Center for AIDS Research (CFAR) and the University of Washington Virology Division, are pleased to host the fourth Conference on Cell & Gene Therapy for HIV Cure in Seattle, Washington on August 17-18, 2017. The event will be held on the campus of the Fred Hutchinson Cancer Research Center.

Born out of the desire to bring much needed attention to HIV cell and gene therapies, this conference aims to advance the pursuit of an HIV cure by bringing together an international roster of esteemed scientists to share and review the latest cell and gene therapy approaches targeting HIV. 

We look forward to building on the success of the first three conferences, held in 2014, 2015 and 2016, and invite HIV and cell and gene therapy researchers, clinicians, young investigators and trainees including pre- and post-doctoral fellows, to participate. Scholarships are available to trainees. We also continue to partner with community advocates, including HIV community advisory board (CAB) members, and are pleased to offer a limited number of community sponsorship and volunteer opportunities.

Ending HIV/AIDS will take a multi-platform approach. It will require prevention, development of a vaccine, and curative therapies. As such, defeatHIV looks forward to hosting this international gathering in 2017 designed to foster scientific collegiality and to continue to build the important scientific collaborations and community relationships that are critical to solving one of the greatest puzzles of global health in human history.

Fred Hutchinson Cancer Research Center
1100 Fairview Ave N

Seattle, WA 98109
United States of America

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects.

An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs.

To learn more visit